Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$2.49 - $3.5 $11,884 - $16,705
4,773 Added 5.91%
85,516 $217,000
Q3 2022

Nov 10, 2022

BUY
$2.82 - $3.58 $47,638 - $60,476
16,893 Added 26.46%
80,743 $226,000
Q2 2022

Aug 12, 2022

SELL
$2.59 - $3.92 $294,350 - $445,504
-113,649 Reduced 64.03%
63,850 $178,000
Q1 2022

May 12, 2022

SELL
$3.0 - $4.25 $292,707 - $414,668
-97,569 Reduced 35.47%
177,499 $688,000
Q4 2021

Feb 11, 2022

SELL
$3.85 - $6.71 $213,944 - $372,874
-55,570 Reduced 16.81%
275,068 $1.08 Million
Q3 2021

Nov 12, 2021

BUY
$5.6 - $8.58 $63,246 - $96,902
11,294 Added 3.54%
330,638 $1.86 Million
Q2 2021

Aug 09, 2021

BUY
$7.16 - $9.41 $791,058 - $1.04 Million
110,483 Added 52.9%
319,344 $2.75 Million
Q1 2021

Apr 30, 2021

SELL
$7.52 - $15.55 $629,213 - $1.3 Million
-83,672 Reduced 28.6%
208,861 $1.97 Million
Q4 2020

Feb 02, 2021

SELL
$5.0 - $8.85 $184,970 - $327,396
-36,994 Reduced 11.23%
292,533 $2.03 Million
Q3 2020

Nov 10, 2020

BUY
$4.96 - $7.08 $44,203 - $63,096
8,912 Added 2.78%
329,527 $1.66 Million
Q2 2020

Aug 12, 2020

BUY
$4.84 - $8.02 $115,071 - $190,675
23,775 Added 8.01%
320,615 $1.93 Million
Q1 2020

May 13, 2020

SELL
$4.52 - $8.55 $244,224 - $461,973
-54,032 Reduced 15.4%
296,840 $1.69 Million
Q4 2019

Feb 12, 2020

BUY
$6.14 - $9.3 $625,088 - $946,795
101,806 Added 40.88%
350,872 $2.69 Million
Q3 2019

Nov 14, 2019

BUY
$9.05 - $16.02 $109,224 - $193,345
12,069 Added 5.09%
249,066 $2.25 Million
Q2 2019

Aug 12, 2019

BUY
$13.58 - $18.61 $2.59 Million - $3.55 Million
190,803 Added 413.05%
236,997 $4.98 Million
Q1 2019

May 08, 2019

SELL
$11.31 - $23.7 $2.85 Million - $5.96 Million
-251,677 Reduced 84.49%
46,194 $1.13 Million
Q4 2018

Sep 06, 2019

BUY
$6.8 - $12.88 $2.03 Million - $3.84 Million
297,871 New
297,871 $3.14 Million

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $756M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.